Monday, January 23, 2017 3:45:17 PM
1. IS saving lives!
2. LL say is her greatest accomplishment! (I'll believe her over you any day.
3. results in the crossover and treatment arm patients living longer!
4. A number of the largest, best run pharmaceuticals are starting trials;
4b. ALL of the best US, UK and Germany cancer treatment centers are testing!
5. that is furthest along in its testing AND manufacturing than any other drug.
6. that has been in trial for 7+ years and have not met 75% events for progression and death yet! When patients are given DCVAx-L, PROGRESSION AND DEATH ARE OCCURRING LESS THAN WITH SOC!
By the way, the sp, halt, dilution, lawsuits, de-listing, sec-inquiry are legitimate concerns. But each one of these can be explained and none negates the science. What is conspicuously missing in your list below are any issues with the science! None of you can say one darn thing bad about it! If the science work, NWBO will overcome every issue you listed. Even you admit that the sp has all of this info factored in the stock price. So those investing in NWBO today, will incur far less risk.
Question: Do you remember when apple was around 1.38? What about IBM. Everyone thought they were going out of business.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM